These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35249379)

  • 1. Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration.
    Örd L; Marandi T; Märk M; Raidjuk L; Kostjuk J; Banys V; Krause K; Pikta M
    Clin Appl Thromb Hemost; 2022; 28():10760296221084307. PubMed ID: 35249379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants.
    Papageorgiou L; Hetjens S; Fareed J; Auge S; Tredler L; Harenberg J; Weiss C; Elalamy I; Gerotziafas GT
    Clin Appl Thromb Hemost; 2023; 29():10760296231179684. PubMed ID: 37278029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation.
    Margetić S; Ćelap I; Huzjan AL; Puretić MB; Goreta SŠ; Glojnarić AČ; Brkljačić DD; Mioč P; Harenberg J; Hetjens S; Weiss C
    Thromb Haemost; 2022 Sep; 122(9):1542-1548. PubMed ID: 35088395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
    Sevenet PO; Cucini V; Hervé T; Depasse F; Carlo A; Contant G; Mathieu O
    Int J Lab Hematol; 2020 Oct; 42(5):636-642. PubMed ID: 32567799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine.
    Harenberg J; Martini A; Du S; Krämer S; Weiss C; Hetjens S
    Clin Appl Thromb Hemost; 2021; 27():1076029621993550. PubMed ID: 33733904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
    Ząbczyk M; Kopytek M; Natorska J; Undas A
    Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of centrifugation time and pneumatic tube transport on plasma concentrations of direct oral anticoagulants.
    Roginski E; Nissen PH; Hojbjerg JA; Grove EL; Hvas AM
    Int J Lab Hematol; 2022 Feb; 44(1):216-222. PubMed ID: 34638165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a Qualitative Point-of-Care Strip Test to Detect DOAC Exposure at the Emergency Department: A Cohort-Type Cross-Sectional Diagnostic Accuracy Study.
    Merrelaar AE; Bögl MS; Buchtele N; Merrelaar M; Herkner H; Schoergenhofer C; Harenberg J; Douxfils J; Siriez R; Jilma B; Spiel AO; Schwameis M
    Thromb Haemost; 2022 Oct; 122(10):1723-1731. PubMed ID: 35785816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
    Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
    Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOAC-Remove abolishes the effect of direct oral anticoagulants on activated protein C resistance testing in real-life venous thromboembolism patients.
    Kopytek M; Ząbczyk M; Malinowski KP; Undas A; Natorska J
    Clin Chem Lab Med; 2020 Feb; 58(3):430-437. PubMed ID: 31539350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM).
    Seyve L; Richarme C; Polack B; Marlu R
    Int J Lab Hematol; 2018 Feb; 40(1):84-93. PubMed ID: 28980758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants.
    Metze M; Klöter T; Stöbe S; Rechenberger B; Siegemund R; Siegemund T; Laufs U; Petros S; Pfrepper C
    Int J Lab Hematol; 2021 Dec; 43(6):1539-1548. PubMed ID: 34097808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick.
    Harenberg J; Schreiner R; Hetjens S; Weiss C
    Semin Thromb Hemost; 2019 Apr; 45(3):275-284. PubMed ID: 30134449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulant adsorption: Impact on lupus anticoagulant testing-Review of the literature and evaluation on spiked and patient samples.
    De Kesel PM; Devreese KMJ
    J Thromb Haemost; 2020 Aug; 18(8):2003-2017. PubMed ID: 32400112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips.
    Harenberg J; Hetjens S; Weiss C
    Clin Appl Thromb Hemost; 2022; 28():10760296221083667. PubMed ID: 35275493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
    Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S
    J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening test for direct oral anticoagulants with the dilute Russell viper venom time.
    Pratt J; Crispin P
    Eur J Haematol; 2018 Jun; 100(6):567-574. PubMed ID: 29486103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R; Grant RP; Adcock DM
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.
    Sennesael AL; Exner T; Chatelain B; Lessire S; Larock AS; Vancraeynest C; Pochet L; Dogné JM; Spinewine A; Mullier F; Douxfils J
    Thromb Res; 2017 Sep; 157():29-37. PubMed ID: 28686914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.